Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSTP1 | P09211 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | LTA4H | P09960 | 5/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 4/20 | 0.38 |
| ▸ | MAOA | P21397 | 4/20 | 0.38 |
| ▸ | ACHE | P22303 | 2/20 | 0.38 |
| ▸ | ACACA | Q13085 | 1/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.36 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.36 |
| ▸ | BAX | Q07812 | 1/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11367683 | 0.92 | GSTP1 (0.43) | GSTP1NPC1POLBRAB9AL3MBTL1 | |
| SCHEMBL14297105 | 0.84 | GSTP1 (0.47) | GSTP1NPC1POLBRAB9AL3MBTL1 | |
| SCHEMBL12011503 | 0.82 | GSTP1 (0.37) | GSTP1NPC1POLBRAB9AL3MBTL1 | |
| SCHEMBL11367640 | 0.82 | ACACA (0.48) | NPC1RAB9AL3MBTL1TSHRMAOB | |
| SCHEMBL3916691 | 0.79 | GSTP1 (0.60) | GSTP1NPC1RAB9ALTA4HTSHR | |
| SCHEMBL13648841 | 0.79 | MAOB (0.48) | GSTP1NPC1POLBRAB9AL3MBTL1 | |
| SCHEMBL23915779 | 0.79 | MEN1 (0.54) | GSTP1NPC1POLBRAB9AL3MBTL1 | |
| SCHEMBL16890581 | 0.79 | MEN1 (0.54) | GSTP1NPC1POLBRAB9AL3MBTL1 | |
| SCHEMBL10015409 | 0.78 | GSTP1 (0.35) | GSTP1NPC1POLBRAB9AL3MBTL1 | |
| SCHEMBL23916224 | 0.77 | MEN1 (0.56) | GSTP1NPC1POLBRAB9AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2216313-B1 | BENZOCHRYSENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | IDEMITSU KOSAN CO (JP) | 2013-02-20 | — | — | EP | disclosed |
| US-8222637-B2 | Benzochrysene derivative and organic electroluminescence device using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2012-07-17 | — | — | US | disclosed |
| US-20100320451-A1 | BENZOCHRYSENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. | 2010-12-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100320451-A1 | BENZOCHRYSENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | NRAS, KSR1, RSU1 | GSTP1 3544/4885NPC1 4801/4885POLB 3034/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.